Arcosa, Inc.
NYSE:ACAIndustrial - Infrastructure Operations
+$1.92 today
- Market cap
- $7.32B
- Beta
- 1.07
- P/E (TTM)
- 29.7
- EPS (TTM)
- $4.54
- Dividend yield
- 0.15%
Volume 0.88M
Average 0.29M
ACA Common Stock Issued
Cash raised by issuing new shares.
Arcosa, Inc.NYSE: ACA
Common Stock Issued · Q2 FY2026 · quarter ended Jun 2026
Common stock issued outflow grows to $0
Q2 FY2026 common stock issued was $0, compared with $0 a year earlier. Trailing-twelve-month common stock issued was $0.
Context
- Common stock issued amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Common stock issued increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly common stock issued holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Cash FlowText generated from reported figures; not investment advice.
Common Stock Issued history
USD · from the cash flow
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Common Stock Issued | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Common Stock Issued vs competitors
How ACA compares with its peers on the latest reported figures
- ACA's LTM Jun 2026 common stock issued of $0 is the 7th largest of the 11 companies compared; the peer median is $0.
- Common stock issued amounts to 0.0% of revenue for ACA, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $24M | — | — | 0.3% | |
| LTM Sep 2026 | $9.33M | +164.5% | — | 0.4% | |
| LTM Jun 2026 | $5.48M | +5.9% | — | 0.1% | |
| LTM Aug 2026 | $3.69M | +12.3% | +14.8% | 0.2% | |
| LTM Mar 2026 | $452K | -92.3% | -36.3% | 0.0% | |
| LTM Mar 2026 | $100K | -200.0% | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
ECGEverus Construction Group, Inc. | LTM Jun 2026 | $0 | — | — | 0.0% |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding ACA) | $0 | +5.9% | -10.7% | 0.0% | |
Competitors are the stored peer set for ACA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 69.6M | 245.8M | 159.2M | 93.7M | 208.4M |
| Depreciation & Amortization | 144.3M | 154.1M | 159.5M | 195M | 223M |
| Deferred Income Tax | 11.9M | 44.8M | 31.8M | 25.2M | 26M |
| Stock-Based Compensation | 18M | 19.1M | 23.9M | 24.3M | 26.4M |
| Change in Working Capital | (50.3M) | (65.3M) | (147.6M) | 185M | (154.2M) |
| Accounts Receivables | (34.3M) | (65.9M) | (47.8M) | 70M | (69.5M) |
| Inventory | (24.6M) | (26.7M) | (83.5M) | 59.2M | (72.6M) |
| Accounts Payables | 34.7M | 27M | 77.2M | (48.3M) | 21.9M |
| Other Working Capital | (26.1M) | 300K | (93.5M) | 104.1M | (34M) |
| Other Non-Cash Items | (27M) | (224.2M) | 34.2M | (21.2M) | 11.5M |
| Operating Cash Flow | 166.5M | 174.3M | 261M | 502M | 341.1M |
| Capital Expenditures | (85.1M) | (138M) | (203.5M) | (189.7M) | (165.6M) |
| Acquisitions (Net) | (505.2M) | 196.5M | (120.9M) | (1.42B) | 17.6M |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 20M | 32.2M | 38.6M | 104.9M | 26.6M |
| Investing Cash Flow | (570.3M) | 90.7M | (285.8M) | (1.51B) | (121.4M) |
| Debt Repayment | 416.8M | (140.2M) | 14.2M | 1.13B | (168.7M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (19.5M) | (27.5M) | (25.2M) | (10.6M) | 0 |
| Dividends Paid | (9.8M) | (9.8M) | (9.8M) | (9.7M) | (10M) |
| Other Financing Activities | (6.6M) | 0 | (10M) | (23.3M) | (12.9M) |
| Financing Cash Flow | 380.9M | (177.5M) | (30.8M) | 1.09B | (191.6M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (22.9M) | 87.5M | (55.6M) | 82.5M | 27.3M |
| Free Cash Flow | 81.4M | 36.3M | 57.5M | 312.3M | 175.5M |
Arcosa, Inc.
NYSE:ACA
Intrinsic Alpha fair value
Locked
Current Price
$149.15
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.